ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Polio (Poliomyelitis) Vaccines - Global Market Insights and Sales Trends 2024
Published Date: November 2023
|
Report Code: QYRE-Auto-5E7574
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Polio Poliomyelitis Vaccines Market Insights and Forecast to 2028
BUY CHAPTERS

Polio (Poliomyelitis) Vaccines - Global Market Insights and Sales Trends 2024

Code: QYRE-Auto-5E7574
Report
November 2023
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi
GSK
Bibcol
Serum Institute
Tiantan biological
IMBCA
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals

Polio (Poliomyelitis) Vaccines - Market Size

The global Polio (Poliomyelitis) Vaccines market size is expected to reach US$ 835.1 million by 2029, growing at a CAGR of 2.3% from 2023 to 2029.

Polio (Poliomyelitis) Vaccines - Market

Polio (Poliomyelitis) Vaccines - Market

Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.
The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2025.
The market is mainly driven by the significant applications of Polio (Poliomyelitis) Vaccines in various end use industries. The expanding demands from the Research & Academic Laboratories, Pharmaceutical & Biotechnology Companies and Others,, are propelling Polio (Poliomyelitis) Vaccines market. Inactivated Polio Vaccine (IPV), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Oral Polio Vaccine (OPV) segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Polio (Poliomyelitis) Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Polio (Poliomyelitis) Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Polio (Poliomyelitis) Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Polio (Poliomyelitis) Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Polio (Poliomyelitis) Vaccines covered in this report include Sanofi, GSK, Bibcol, Serum Institute, Tiantan Biological, IMBCA, Panacea Biotec Ltd, Bio-Med and Halfkin Bio-Pharmaceuticals, etc.
The global Polio (Poliomyelitis) Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
IMBCA
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals

Scope of Polio (Poliomyelitis) Vaccines - Market Report

Report Metric Details
Report Name Polio (Poliomyelitis) Vaccines - Market
Forecasted market size in 2029 US$ 835.1 million
CAGR 2.3%
Forecasted years 2023 - 2029
Global Polio (Poliomyelitis) Vaccines market, by region:
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Polio (Poliomyelitis) Vaccines market, Segment by Type:
  • Inactivated Polio Vaccine (IPV)
  • Oral Polio Vaccine (OPV)
Global Polio (Poliomyelitis) Vaccines market, by Application
  • Research & Academic Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Others
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
  • Chapter Two: Detailed analysis of Polio (Poliomyelitis) Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter Three: Sales, revenue of Polio (Poliomyelitis) Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
  • Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
  • Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
  • Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter Twelve: Analysis of sales channel, distributors and customers.
  • Chapter Thirteen: Research Findings and Conclusion.

FAQ for this report

What is the Polio (Poliomyelitis) Vaccines - Market size in 2029?

Ans: The Polio (Poliomyelitis) Vaccines - Market size in 2029 will be US$ 835.1 million.

What are the Application segmentation covered in the Polio (Poliomyelitis) Vaccines - Market report?

Ans: The Applications covered in the Polio (Poliomyelitis) Vaccines - Market report are Research & Academic Laboratories, Pharmaceutical & Biotechnology Companies, Others

What are the Type segmentation covered in the Polio (Poliomyelitis) Vaccines - Market report?

Ans: The Types covered in the Polio (Poliomyelitis) Vaccines - Market report are Inactivated Polio Vaccine (IPV), Oral Polio Vaccine (OPV)

1 Polio (Poliomyelitis) Vaccines Market Overview
1.1 Polio (Poliomyelitis) Vaccines Product Overview
1.2 Polio (Poliomyelitis) Vaccines Market Segment by Type
1.2.1 Inactivated Polio Vaccine (IPV)
1.2.2 Oral Polio Vaccine (OPV)
1.3 Global Polio (Poliomyelitis) Vaccines Market Size by Type
1.3.1 Global Polio (Poliomyelitis) Vaccines Market Size Overview by Type (2018-2029)
1.3.2 Global Polio (Poliomyelitis) Vaccines Historic Market Size Review by Type (2018-2023)
1.3.3 Global Polio (Poliomyelitis) Vaccines Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Polio (Poliomyelitis) Vaccines Sales Breakdown by Type (2018-2023)
1.4.2 Europe Polio (Poliomyelitis) Vaccines Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Polio (Poliomyelitis) Vaccines Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Polio (Poliomyelitis) Vaccines Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Polio (Poliomyelitis) Vaccines Sales Breakdown by Type (2018-2023)
2 Global Polio (Poliomyelitis) Vaccines Market Competition by Company
2.1 Global Top Players by Polio (Poliomyelitis) Vaccines Sales (2018-2023)
2.2 Global Top Players by Polio (Poliomyelitis) Vaccines Revenue (2018-2023)
2.3 Global Top Players by Polio (Poliomyelitis) Vaccines Price (2018-2023)
2.4 Global Top Manufacturers Polio (Poliomyelitis) Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Polio (Poliomyelitis) Vaccines Market Competitive Situation and Trends
2.5.1 Polio (Poliomyelitis) Vaccines Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Polio (Poliomyelitis) Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Polio (Poliomyelitis) Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into Polio (Poliomyelitis) Vaccines Market
2.8 Key Manufacturers Polio (Poliomyelitis) Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Polio (Poliomyelitis) Vaccines Status and Outlook by Region
3.1 Global Polio (Poliomyelitis) Vaccines Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Polio (Poliomyelitis) Vaccines Historic Market Size by Region
3.2.1 Global Polio (Poliomyelitis) Vaccines Sales in Volume by Region (2018-2023)
3.2.2 Global Polio (Poliomyelitis) Vaccines Sales in Value by Region (2018-2023)
3.2.3 Global Polio (Poliomyelitis) Vaccines Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Polio (Poliomyelitis) Vaccines Forecasted Market Size by Region
3.3.1 Global Polio (Poliomyelitis) Vaccines Sales in Volume by Region (2024-2029)
3.3.2 Global Polio (Poliomyelitis) Vaccines Sales in Value by Region (2024-2029)
3.3.3 Global Polio (Poliomyelitis) Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Polio (Poliomyelitis) Vaccines by Application
4.1 Polio (Poliomyelitis) Vaccines Market Segment by Application
4.1.1 Research & Academic Laboratories
4.1.2 Pharmaceutical & Biotechnology Companies
4.1.3 Others
4.2 Global Polio (Poliomyelitis) Vaccines Market Size by Application
4.2.1 Global Polio (Poliomyelitis) Vaccines Market Size Overview by Application (2018-2029)
4.2.2 Global Polio (Poliomyelitis) Vaccines Historic Market Size Review by Application (2018-2023)
4.2.3 Global Polio (Poliomyelitis) Vaccines Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Polio (Poliomyelitis) Vaccines Sales Breakdown by Application (2018-2023)
4.3.2 Europe Polio (Poliomyelitis) Vaccines Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Polio (Poliomyelitis) Vaccines Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Polio (Poliomyelitis) Vaccines Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Polio (Poliomyelitis) Vaccines Sales Breakdown by Application (2018-2023)
5 North America Polio (Poliomyelitis) Vaccines by Country
5.1 North America Polio (Poliomyelitis) Vaccines Historic Market Size by Country
5.1.1 North America Polio (Poliomyelitis) Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Polio (Poliomyelitis) Vaccines Sales in Volume by Country (2018-2023)
5.1.3 North America Polio (Poliomyelitis) Vaccines Sales in Value by Country (2018-2023)
5.2 North America Polio (Poliomyelitis) Vaccines Forecasted Market Size by Country
5.2.1 North America Polio (Poliomyelitis) Vaccines Sales in Volume by Country (2024-2029)
5.2.2 North America Polio (Poliomyelitis) Vaccines Sales in Value by Country (2024-2029)
6 Europe Polio (Poliomyelitis) Vaccines by Country
6.1 Europe Polio (Poliomyelitis) Vaccines Historic Market Size by Country
6.1.1 Europe Polio (Poliomyelitis) Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Polio (Poliomyelitis) Vaccines Sales in Volume by Country (2018-2023)
6.1.3 Europe Polio (Poliomyelitis) Vaccines Sales in Value by Country (2018-2023)
6.2 Europe Polio (Poliomyelitis) Vaccines Forecasted Market Size by Country
6.2.1 Europe Polio (Poliomyelitis) Vaccines Sales in Volume by Country (2024-2029)
6.2.2 Europe Polio (Poliomyelitis) Vaccines Sales in Value by Country (2024-2029)
7 Asia-Pacific Polio (Poliomyelitis) Vaccines by Region
7.1 Asia-Pacific Polio (Poliomyelitis) Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Polio (Poliomyelitis) Vaccines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Polio (Poliomyelitis) Vaccines Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Polio (Poliomyelitis) Vaccines Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Polio (Poliomyelitis) Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Polio (Poliomyelitis) Vaccines Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Polio (Poliomyelitis) Vaccines Sales in Value by Region (2024-2029)
8 Latin America Polio (Poliomyelitis) Vaccines by Country
8.1 Latin America Polio (Poliomyelitis) Vaccines Historic Market Size by Country
8.1.1 Latin America Polio (Poliomyelitis) Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Polio (Poliomyelitis) Vaccines Sales in Volume by Country (2018-2023)
8.1.3 Latin America Polio (Poliomyelitis) Vaccines Sales in Value by Country (2018-2023)
8.2 Latin America Polio (Poliomyelitis) Vaccines Forecasted Market Size by Country
8.2.1 Latin America Polio (Poliomyelitis) Vaccines Sales in Volume by Country (2024-2029)
8.2.2 Latin America Polio (Poliomyelitis) Vaccines Sales in Value by Country (2024-2029)
9 Middle East and Africa Polio (Poliomyelitis) Vaccines by Country
9.1 Middle East and Africa Polio (Poliomyelitis) Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Polio (Poliomyelitis) Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Polio (Poliomyelitis) Vaccines Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Polio (Poliomyelitis) Vaccines Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Polio (Poliomyelitis) Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Polio (Poliomyelitis) Vaccines Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Polio (Poliomyelitis) Vaccines Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Sanofi
10.1.1 Sanofi Company Information
10.1.2 Sanofi Introduction and Business Overview
10.1.3 Sanofi Polio (Poliomyelitis) Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Sanofi Polio (Poliomyelitis) Vaccines Products Offered
10.1.5 Sanofi Recent Development
10.2 GSK
10.2.1 GSK Company Information
10.2.2 GSK Introduction and Business Overview
10.2.3 GSK Polio (Poliomyelitis) Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.2.4 GSK Polio (Poliomyelitis) Vaccines Products Offered
10.2.5 GSK Recent Development
10.3 Bibcol
10.3.1 Bibcol Company Information
10.3.2 Bibcol Introduction and Business Overview
10.3.3 Bibcol Polio (Poliomyelitis) Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Bibcol Polio (Poliomyelitis) Vaccines Products Offered
10.3.5 Bibcol Recent Development
10.4 Serum Institute
10.4.1 Serum Institute Company Information
10.4.2 Serum Institute Introduction and Business Overview
10.4.3 Serum Institute Polio (Poliomyelitis) Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Serum Institute Polio (Poliomyelitis) Vaccines Products Offered
10.4.5 Serum Institute Recent Development
10.5 Tiantan Biological
10.5.1 Tiantan Biological Company Information
10.5.2 Tiantan Biological Introduction and Business Overview
10.5.3 Tiantan Biological Polio (Poliomyelitis) Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Tiantan Biological Polio (Poliomyelitis) Vaccines Products Offered
10.5.5 Tiantan Biological Recent Development
10.6 IMBCA
10.6.1 IMBCA Company Information
10.6.2 IMBCA Introduction and Business Overview
10.6.3 IMBCA Polio (Poliomyelitis) Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.6.4 IMBCA Polio (Poliomyelitis) Vaccines Products Offered
10.6.5 IMBCA Recent Development
10.7 Panacea Biotec Ltd
10.7.1 Panacea Biotec Ltd Company Information
10.7.2 Panacea Biotec Ltd Introduction and Business Overview
10.7.3 Panacea Biotec Ltd Polio (Poliomyelitis) Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Panacea Biotec Ltd Polio (Poliomyelitis) Vaccines Products Offered
10.7.5 Panacea Biotec Ltd Recent Development
10.8 Bio-Med
10.8.1 Bio-Med Company Information
10.8.2 Bio-Med Introduction and Business Overview
10.8.3 Bio-Med Polio (Poliomyelitis) Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Bio-Med Polio (Poliomyelitis) Vaccines Products Offered
10.8.5 Bio-Med Recent Development
10.9 Halfkin Bio-Pharmaceuticals
10.9.1 Halfkin Bio-Pharmaceuticals Company Information
10.9.2 Halfkin Bio-Pharmaceuticals Introduction and Business Overview
10.9.3 Halfkin Bio-Pharmaceuticals Polio (Poliomyelitis) Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Halfkin Bio-Pharmaceuticals Polio (Poliomyelitis) Vaccines Products Offered
10.9.5 Halfkin Bio-Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Polio (Poliomyelitis) Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Polio (Poliomyelitis) Vaccines Industrial Chain Analysis
11.4 Polio (Poliomyelitis) Vaccines Market Dynamics
11.4.1 Polio (Poliomyelitis) Vaccines Industry Trends
11.4.2 Polio (Poliomyelitis) Vaccines Market Drivers
11.4.3 Polio (Poliomyelitis) Vaccines Market Challenges
11.4.4 Polio (Poliomyelitis) Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Polio (Poliomyelitis) Vaccines Distributors
12.3 Polio (Poliomyelitis) Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Sanofi
GSK
Bibcol
Serum Institute
Tiantan biological
IMBCA
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
List of Tables
    Table 1. Major Company of Inactivated Polio Vaccine (IPV)
    Table 2. Major Company of Oral Polio Vaccine (OPV)
    Table 3. Global Polio (Poliomyelitis) Vaccines Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
    Table 4. Global Polio (Poliomyelitis) Vaccines Sales by Type (2018-2023) & (K Units)
    Table 5. Global Polio (Poliomyelitis) Vaccines Sales Market Share in Volume by Type (2018-2023)
    Table 6. Global Polio (Poliomyelitis) Vaccines Sales by Type (2018-2023) & (US& Million)
    Table 7. Global Polio (Poliomyelitis) Vaccines Market Share in Value by Type (2018-2023)
    Table 8. Global Polio (Poliomyelitis) Vaccines Price by Type (2018-2023) & (USD/Unit)
    Table 9. Global Polio (Poliomyelitis) Vaccines Sales by Type (2024-2029) & (K Units)
    Table 10. Global Polio (Poliomyelitis) Vaccines Sales Market Share in Volume by Type (2024-2029)
    Table 11. Global Polio (Poliomyelitis) Vaccines Sales by Type (2024-2029) & (US$ Million)
    Table 12. Global Polio (Poliomyelitis) Vaccines Sales Market Share in Value by Type (2024-2029)
    Table 13. Global Polio (Poliomyelitis) Vaccines Price by Type (2024-2029) & (USD/Unit)
    Table 14. North America Polio (Poliomyelitis) Vaccines Sales by Type (2018-2023) & (K Units)
    Table 15. North America Polio (Poliomyelitis) Vaccines Sales by Type (2018-2023) & (US$ Million)
    Table 16. Europe Polio (Poliomyelitis) Vaccines Sales (K Units) by Type (2018-2023)
    Table 17. Europe Polio (Poliomyelitis) Vaccines Sales by Type (2018-2023) & (US$ Million)
    Table 18. Asia-Pacific Polio (Poliomyelitis) Vaccines Sales (K Units) by Type (2018-2023)
    Table 19. Asia-Pacific Polio (Poliomyelitis) Vaccines Sales by Type (2018-2023) & (US$ Million)
    Table 20. Latin America Polio (Poliomyelitis) Vaccines Sales (K Units) by Type (2018-2023)
    Table 21. Latin America Polio (Poliomyelitis) Vaccines Sales by Type (2018-2023) & (US$ Million)
    Table 22. Middle East and Africa Polio (Poliomyelitis) Vaccines Sales (K Units) by Type (2018-2023)
    Table 23. Middle East and Africa Polio (Poliomyelitis) Vaccines Sales by Type (2018-2023) & (US$ Million)
    Table 24. Global Polio (Poliomyelitis) Vaccines Sales by Company (2018-2023) & (K Units)
    Table 25. Global Polio (Poliomyelitis) Vaccines Sales Share by Company (2018-2023)
    Table 26. Global Polio (Poliomyelitis) Vaccines Revenue by Company (2018-2023) & (US$ Million)
    Table 27. Global Polio (Poliomyelitis) Vaccines Revenue Share by Company (2018-2023)
    Table 28. Global Market Polio (Poliomyelitis) Vaccines Price by Company (2018-2023) & (USD/Unit)
    Table 29. Global Polio (Poliomyelitis) Vaccines Top Manufacturers Manufacturing Base Distribution and Sales Area
    Table 30. Global Polio (Poliomyelitis) Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Polio (Poliomyelitis) Vaccines as of 2022)
    Table 32. Date of Key Manufacturers Enter into Polio (Poliomyelitis) Vaccines Market
    Table 33. Key Manufacturers Polio (Poliomyelitis) Vaccines Product Type
    Table 34. Mergers & Acquisitions, Expansion Plans
    Table 35. Global Polio (Poliomyelitis) Vaccines Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 36. Global Polio (Poliomyelitis) Vaccines Sales by Region (2018-2023) & (K Units)
    Table 37. Global Polio (Poliomyelitis) Vaccines Sales Market Share in Volume by Region (2018-2023)
    Table 38. Global Polio (Poliomyelitis) Vaccines Sales by Region (2018-2023) & (US$ Million)
    Table 39. Global Polio (Poliomyelitis) Vaccines Sales Market Share in Value by Region (2018-2023)
    Table 40. Global Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 41. Global Polio (Poliomyelitis) Vaccines Sales by Region (2024-2029) & (K Units)
    Table 42. Global Polio (Poliomyelitis) Vaccines Sales Market Share in Volume by Region (2024-2029)
    Table 43. Global Polio (Poliomyelitis) Vaccines Sales by Region (2024-2029) & (US$ Million)
    Table 44. Global Polio (Poliomyelitis) Vaccines Sales Market Share in Value by Region (2024-2029)
    Table 45. Global Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2029)
    Table 46. Global Polio (Poliomyelitis) Vaccines Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 47. Global Polio (Poliomyelitis) Vaccines Sales by Application (2018-2023) & (K Units)
    Table 48. Global Polio (Poliomyelitis) Vaccines Sales Market Share in Volume by Application (2018-2023)
    Table 49. Global Polio (Poliomyelitis) Vaccines Sales by Application (2018-2023) & (US$ Million)
    Table 50. Global Polio (Poliomyelitis) Vaccines Sales Market Share in Value by Application (2018-2023)
    Table 51. Global Polio (Poliomyelitis) Vaccines Price by Application (2018-2023) & (USD/Unit)
    Table 52. Global Polio (Poliomyelitis) Vaccines Sales by Application (2024-2029) & (K Units)
    Table 53. Global Polio (Poliomyelitis) Vaccines Sales Market Share in Volume by Application (2024-2029)
    Table 54. Global Polio (Poliomyelitis) Vaccines Sales by Application (2024-2029) & (US$ Million)
    Table 55. Global Polio (Poliomyelitis) Vaccines Sales Market Share in Value by Application (2024-2029)
    Table 56. Global Polio (Poliomyelitis) Vaccines Price by Application (2024-2029) & (USD/Unit)
    Table 57. North America Polio (Poliomyelitis) Vaccines Sales by Application (2018-2023) (K Units)
    Table 58. North America Polio (Poliomyelitis) Vaccines Sales by Application (2018-2023) & (US$ Million)
    Table 59. Europe Polio (Poliomyelitis) Vaccines Sales by Application (2018-2023) (K Units)
    Table 60. Europe Polio (Poliomyelitis) Vaccines Sales by Application (2018-2023) & (US$ Million)
    Table 61. Asia-Pacific Polio (Poliomyelitis) Vaccines Sales by Application (2018-2023) (K Units)
    Table 62. Asia-Pacific Polio (Poliomyelitis) Vaccines Sales by Application (2018-2023) & (US$ Million)
    Table 63. Latin America Polio (Poliomyelitis) Vaccines Sales by Application (2018-2023) (K Units)
    Table 64. Latin America Polio (Poliomyelitis) Vaccines Sales by Application (2018-2023) & (US$ Million)
    Table 65. Middle East and Africa Polio (Poliomyelitis) Vaccines Sales by Application (2018-2023) (K Units)
    Table 66. Middle East and Africa Polio (Poliomyelitis) Vaccines Sales by Application (2018-2023) & (US$ Million)
    Table 67. North America Polio (Poliomyelitis) Vaccines Sales by Country (2018-2023) & (K Units)
    Table 68. North America Polio (Poliomyelitis) Vaccines Sales Market Share in Volume by Country (2018-2023)
    Table 69. North America Polio (Poliomyelitis) Vaccines Sales by Country (2018-2023) & (US$ Million)
    Table 70. North America Polio (Poliomyelitis) Vaccines Sales Market Share in Value by Country (2018-2023)
    Table 71. North America Polio (Poliomyelitis) Vaccines Sales by Country (2024-2029) & (K Units)
    Table 72. North America Polio (Poliomyelitis) Vaccines Sales Market Share in Volume by Country (2024-2029)
    Table 73. North America Polio (Poliomyelitis) Vaccines Sales by Country (2024-2029) & (US$ Million)
    Table 74. North America Polio (Poliomyelitis) Vaccines Sales Market Share in Value by Country (2024-2029)
    Table 75. Europe Polio (Poliomyelitis) Vaccines Sales by Country (2018-2023) & (K Units)
    Table 76. Europe Polio (Poliomyelitis) Vaccines Sales Market Share in Volume by Country (2018-2023)
    Table 77. Europe Polio (Poliomyelitis) Vaccines Sales by Country (2018-2023) & (US$ Million)
    Table 78. Europe Polio (Poliomyelitis) Vaccines Sales Market Share in Value by Country (2018-2023)
    Table 79. Europe Polio (Poliomyelitis) Vaccines Sales by Country (2024-2029) & (K Units)
    Table 80. Europe Polio (Poliomyelitis) Vaccines Sales Market Share in Volume by Country (2024-2029)
    Table 81. Europe Polio (Poliomyelitis) Vaccines Sales by Country (2024-2029) & (US$ Million)
    Table 82. Europe Polio (Poliomyelitis) Vaccines Sales Market Share in Value by Country (2024-2029)
    Table 83. Asia-Pacific Polio (Poliomyelitis) Vaccines Sales by Region (2018-2023) & (K Units)
    Table 84. Asia-Pacific Polio (Poliomyelitis) Vaccines Sales Market Share in Volume by Region (2018-2023)
    Table 85. Asia-Pacific Polio (Poliomyelitis) Vaccines Sales by Region (2018-2023) & (US$ Million)
    Table 86. Asia-Pacific Polio (Poliomyelitis) Vaccines Sales Market Share in Value by Region (2018-2023)
    Table 87. Asia-Pacific Polio (Poliomyelitis) Vaccines Sales by Region (2024-2029) & (K Units)
    Table 88. Asia-Pacific Polio (Poliomyelitis) Vaccines Sales Market Share in Volume by Region (2024-2029)
    Table 89. Asia-Pacific Polio (Poliomyelitis) Vaccines Sales by Region (2024-2029) & (US$ Million)
    Table 90. Asia-Pacific Polio (Poliomyelitis) Vaccines Sales Market Share in Value by Region (2024-2029)
    Table 91. Latin America Polio (Poliomyelitis) Vaccines Sales by Country (2018-2023) & (K Units)
    Table 92. Latin America Polio (Poliomyelitis) Vaccines Sales Market Share in Volume by Country (2018-2023)
    Table 93. Latin America Polio (Poliomyelitis) Vaccines Sales by Country (2018-2023) & (US$ Million)
    Table 94. Latin America Polio (Poliomyelitis) Vaccines Sales Market Share in Value by Country (2018-2023)
    Table 95. Latin America Polio (Poliomyelitis) Vaccines Sales by Country (2024-2029) & (K Units)
    Table 96. Latin America Polio (Poliomyelitis) Vaccines Sales Market Share in Volume by Country (2024-2029)
    Table 97. Latin America Polio (Poliomyelitis) Vaccines Sales by Country (2024-2029) & (US$ Million)
    Table 98. Latin America Polio (Poliomyelitis) Vaccines Sales Market Share in Value by Country (2024-2029)
    Table 99. Middle East and Africa Polio (Poliomyelitis) Vaccines Sales by Country (2018-2023) & (K Units)
    Table 100. Middle East and Africa Polio (Poliomyelitis) Vaccines Sales Market Share in Volume by Country (2018-2023)
    Table 101. Middle East and Africa Polio (Poliomyelitis) Vaccines Sales by Country (2018-2023) & (US$ Million)
    Table 102. Middle East and Africa Polio (Poliomyelitis) Vaccines Sales Market Share in Value by Country (2018-2023)
    Table 103. Middle East and Africa Polio (Poliomyelitis) Vaccines Sales by Country (2024-2029) & (K Units)
    Table 104. Middle East and Africa Polio (Poliomyelitis) Vaccines Sales Market Share in Volume by Country (2024-2029)
    Table 105. Middle East and Africa Polio (Poliomyelitis) Vaccines Sales by Country (2024-2029) & (US$ Million)
    Table 106. Middle East and Africa Polio (Poliomyelitis) Vaccines Sales Market Share in Value by Country (2024-2029)
    Table 107. Sanofi Company Information
    Table 108. Sanofi Introduction and Business Overview
    Table 109. Sanofi Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 110. Sanofi Polio (Poliomyelitis) Vaccines Product
    Table 111. Sanofi Recent Development
    Table 112. GSK Company Information
    Table 113. GSK Introduction and Business Overview
    Table 114. GSK Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 115. GSK Polio (Poliomyelitis) Vaccines Product
    Table 116. GSK Recent Development
    Table 117. Bibcol Company Information
    Table 118. Bibcol Introduction and Business Overview
    Table 119. Bibcol Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 120. Bibcol Polio (Poliomyelitis) Vaccines Product
    Table 121. Bibcol Recent Development
    Table 122. Serum Institute Company Information
    Table 123. Serum Institute Introduction and Business Overview
    Table 124. Serum Institute Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 125. Serum Institute Polio (Poliomyelitis) Vaccines Product
    Table 126. Serum Institute Recent Development
    Table 127. Tiantan Biological Company Information
    Table 128. Tiantan Biological Introduction and Business Overview
    Table 129. Tiantan Biological Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 130. Tiantan Biological Polio (Poliomyelitis) Vaccines Product
    Table 131. Tiantan Biological Recent Development
    Table 132. IMBCA Company Information
    Table 133. IMBCA Introduction and Business Overview
    Table 134. IMBCA Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 135. IMBCA Polio (Poliomyelitis) Vaccines Product
    Table 136. IMBCA Recent Development
    Table 137. Panacea Biotec Ltd Company Information
    Table 138. Panacea Biotec Ltd Introduction and Business Overview
    Table 139. Panacea Biotec Ltd Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 140. Panacea Biotec Ltd Polio (Poliomyelitis) Vaccines Product
    Table 141. Panacea Biotec Ltd Recent Development
    Table 142. Bio-Med Company Information
    Table 143. Bio-Med Introduction and Business Overview
    Table 144. Bio-Med Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 145. Bio-Med Polio (Poliomyelitis) Vaccines Product
    Table 146. Bio-Med Recent Development
    Table 147. Halfkin Bio-Pharmaceuticals Company Information
    Table 148. Halfkin Bio-Pharmaceuticals Introduction and Business Overview
    Table 149. Halfkin Bio-Pharmaceuticals Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 150. Halfkin Bio-Pharmaceuticals Polio (Poliomyelitis) Vaccines Product
    Table 151. Halfkin Bio-Pharmaceuticals Recent Development
    Table 152. Key Raw Materials Lists
    Table 153. Raw Materials Key Suppliers Lists
    Table 154. Polio (Poliomyelitis) Vaccines Market Trends
    Table 155. Polio (Poliomyelitis) Vaccines Market Drivers
    Table 156. Polio (Poliomyelitis) Vaccines Market Challenges
    Table 157. Polio (Poliomyelitis) Vaccines Market Restraints
    Table 158. Polio (Poliomyelitis) Vaccines Distributors List
    Table 159. Polio (Poliomyelitis) Vaccines Downstream Customers
    Table 160. Research Programs/Design for This Report
    Table 161. Key Data Information from Secondary Sources
    Table 162. Key Data Information from Primary Sources
List of Figures
    Figure 1. Polio (Poliomyelitis) Vaccines Product Picture
    Figure 2. Global Polio (Poliomyelitis) Vaccines Market Size, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 3. Global Polio (Poliomyelitis) Vaccines Market Size Status and Outlook (2018-2029) & (US$ Million)
    Figure 4. Global Polio (Poliomyelitis) Vaccines Sales Status and Outlook (2018-2029) & (K Units)
    Figure 5. Product Picture of Inactivated Polio Vaccine (IPV)
    Figure 6. Global Inactivated Polio Vaccine (IPV) Sales YoY Growth (2018-2029) & (K Units)
    Figure 7. Product Picture of Oral Polio Vaccine (OPV)
    Figure 8. Global Oral Polio Vaccine (OPV) Sales YoY Growth (2018-2029) & (K Units)
    Figure 9. Global Polio (Poliomyelitis) Vaccines Sales by Type (2018-2029) & (US$ Million)
    Figure 10. Global Polio (Poliomyelitis) Vaccines Sales Market Share by Type in 2022 & 2029
    Figure 11. North America Polio (Poliomyelitis) Vaccines Sales Market Share in Volume by Type in 2022
    Figure 12. North America Polio (Poliomyelitis) Vaccines Sales Market Share in Value by Type in 2022
    Figure 13. Europe Polio (Poliomyelitis) Vaccines Sales Market Share in Volume by Type in 2022
    Figure 14. Europe Polio (Poliomyelitis) Vaccines Sales Market Share in Value by Type in 2022
    Figure 15. Asia-Pacific Polio (Poliomyelitis) Vaccines Sales Market Share in Volume by Type in 2022
    Figure 16. Asia-Pacific Polio (Poliomyelitis) Vaccines Sales Market Share in Value by Type in 2022
    Figure 17. Latin America Polio (Poliomyelitis) Vaccines Sales Market Share in Volume by Type in 2022
    Figure 18. Latin America Polio (Poliomyelitis) Vaccines Sales Market Share in Value by Type in 2022
    Figure 19. Middle East and Africa Polio (Poliomyelitis) Vaccines Sales Market Share in Volume by Type in 2022
    Figure 20. Middle East and Africa Polio (Poliomyelitis) Vaccines Sales Market Share in Value by Type in 2022
    Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Polio (Poliomyelitis) Vaccines Sales in 2022
    Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Polio (Poliomyelitis) Vaccines Revenue in 2022
    Figure 23. Polio (Poliomyelitis) Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
    Figure 24. Product Picture of Research & Academic Laboratories
    Figure 25. Global Research & Academic Laboratories Sales YoY Growth (2018-2029) & (K Units)
    Figure 26. Product Picture of Pharmaceutical & Biotechnology Companies
    Figure 27. Global Pharmaceutical & Biotechnology Companies Sales YoY Growth (2018-2029) & (K Units)
    Figure 28. Product Picture of Others
    Figure 29. Global Others Sales YoY Growth (2018-2029) & (K Units)
    Figure 30. Global Polio (Poliomyelitis) Vaccines Sales by Application (2018-2029) & (US$ Million)
    Figure 31. Global Polio (Poliomyelitis) Vaccines Sales Market Share by Application in 2022 & 2029
    Figure 32. North America Polio (Poliomyelitis) Vaccines Sales Market Share in Volume by Application in 2022
    Figure 33. North America Polio (Poliomyelitis) Vaccines Sales Market Share in Value by Application in 2022
    Figure 34. Europe Polio (Poliomyelitis) Vaccines Sales Market Share in Volume by Application in 2022
    Figure 35. Europe Polio (Poliomyelitis) Vaccines Sales Market Share in Value by Application in 2022
    Figure 36. Asia-Pacific Polio (Poliomyelitis) Vaccines Sales Market Share in Volume by Application in 2022
    Figure 37. Asia-Pacific Polio (Poliomyelitis) Vaccines Sales Market Share in Value by Application in 2022
    Figure 38. Latin America Polio (Poliomyelitis) Vaccines Sales Market Share in Volume by Application in 2022
    Figure 39. Latin America Polio (Poliomyelitis) Vaccines Sales Market Share in Value by Application in 2022
    Figure 40. Middle East and Africa Polio (Poliomyelitis) Vaccines Sales Market Share in Value by Application in 2022
    Figure 41. Key Raw Materials Price
    Figure 42. Polio (Poliomyelitis) Vaccines Manufacturing Cost Structure
    Figure 43. Polio (Poliomyelitis) Vaccines Industrial Chain Analysis
    Figure 44. Channels of Distribution
    Figure 45. Distributors Profiles
    Figure 46. Bottom-up and Top-down Approaches for This Report
    Figure 47. Data Triangulation
    Figure 48. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3350

This license allows only one user to access the PDF.
Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions